drugset / Trial / NCT00683514

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

NCT00683514

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multicenter, open-label, randomised, phase III study of 2 cycles of oral vinorelbine in combination with cisplatin concurrently with radiotherapy randomised to either two more cycles of consolidation therapy with oral vinorelbine and cisplatin plus Best Supportive Care (BSC) or BSC alone in patients with unresectable locally advanced non small cell lung cancer (NSCLC). The primary objective is to compare progression-free survival in both arms, the secondary is to evaluate the response rate, overall survival in both arms, to evaluate the safety profile in both arms and to assess quality of life by the LCSS questionnaire.

Timeline

Start
2005-04
Primary completion
2011-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 20 mg/m2
Subject Cisplatin Other / unclassified 80 mg/m2
Subject Vinorelbine Small molecule 50 mg/m2 Oral
Subject Vinorelbine Small molecule 80 mg/m2 Oral